| Anita Naik, MD | |
|
602 S Atwood Rd, Suite 206, Bel Air, MD 21014-4172 | |
| (410) 638-7544 | |
| (410) 638-2221 |
| Full Name | Anita Naik |
|---|---|
| Gender | Female |
| Speciality | Pulmonary Disease |
| Experience | 28 Years |
| Location | 602 S Atwood Rd, Bel Air, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154455756 | NPI | - | NPPES |
| 62116401 | Other | MD | BC BS MARYLAND |
| 2358590 | Other | UNITED | |
| E5540030 | Other | MD | BLUE CHOICE |
| P00075221 | Other | RR MEDICARE |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medstar Franklin Square Medical Center | Baltimore, MD | Hospital |
| Umd Upper Chesapeake Medical Center | Bel air, MD | Hospital |
| Medstar Good Samaritan Hospital | Baltimore, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medstar Medical Group Ii Llc | 0547413825 | 1776 |
News Archive
A team of Cleveland Clinic researchers have discovered a key pathway that leads to recurrence and treatment resistance in endometrial cancer, providing the potential for much needed new therapies for women with limited options.
The University of Minnesota is one of two institutions in the United States to host a new center established by the Biostasis Research Institute aimed at creating human organ banks through the cryogenic storage of organs donated for transplantation.
Galectin Therapeutics Inc., the leader in developing carbohydrate-based therapeutic compounds to inhibit galectin receptors, today announced the formation of its Liver Fibrosis Clinical Trials Advisory Board comprised of key opinion leaders from Emory Hospital and School of Medicine, Massachusetts General Hospital and Harvard School of Medicine, University of Michigan Hospital and School of Medicine, Mount Sinai Hospital and School of Medicine, and University of Wisconsin Hospital and School of Medicine.
The George Washington University School of Public Health and Health Services (GW) today released a report representing consensus findings from a cross-section of stakeholders that could help transform the process used to evaluate interventions to treat obesity, a public health crisis that now affects one in three adults. The report, "Obesity Drug Outcome Measures," results from a stakeholder dialogue group convened by GW that, over a period of nine months, explored why development and approval of obesity drugs have proven so difficult.
Patients undergoing percutaneous coronary intervention (PCI), a coronary artery widening procedureused to treat heart disease, are at high risk for obstructive sleep apnea (OSA), according to new research presented at the 2015 American Thoracic Society International Conference.
› Verified 1 days ago
| Entity Name | Medstar Medical Group Ii Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184046187 PECOS PAC ID: 0547413825 Enrollment ID: O20130117000347 |
News Archive
A team of Cleveland Clinic researchers have discovered a key pathway that leads to recurrence and treatment resistance in endometrial cancer, providing the potential for much needed new therapies for women with limited options.
The University of Minnesota is one of two institutions in the United States to host a new center established by the Biostasis Research Institute aimed at creating human organ banks through the cryogenic storage of organs donated for transplantation.
Galectin Therapeutics Inc., the leader in developing carbohydrate-based therapeutic compounds to inhibit galectin receptors, today announced the formation of its Liver Fibrosis Clinical Trials Advisory Board comprised of key opinion leaders from Emory Hospital and School of Medicine, Massachusetts General Hospital and Harvard School of Medicine, University of Michigan Hospital and School of Medicine, Mount Sinai Hospital and School of Medicine, and University of Wisconsin Hospital and School of Medicine.
The George Washington University School of Public Health and Health Services (GW) today released a report representing consensus findings from a cross-section of stakeholders that could help transform the process used to evaluate interventions to treat obesity, a public health crisis that now affects one in three adults. The report, "Obesity Drug Outcome Measures," results from a stakeholder dialogue group convened by GW that, over a period of nine months, explored why development and approval of obesity drugs have proven so difficult.
Patients undergoing percutaneous coronary intervention (PCI), a coronary artery widening procedureused to treat heart disease, are at high risk for obstructive sleep apnea (OSA), according to new research presented at the 2015 American Thoracic Society International Conference.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anita Naik, MD 501 Fairmount Ave Ste 103, Towson, MD 21286-5457 Ph: (410) 494-7921 | Anita Naik, MD 602 S Atwood Rd, Suite 206, Bel Air, MD 21014-4172 Ph: (410) 638-7544 |
News Archive
A team of Cleveland Clinic researchers have discovered a key pathway that leads to recurrence and treatment resistance in endometrial cancer, providing the potential for much needed new therapies for women with limited options.
The University of Minnesota is one of two institutions in the United States to host a new center established by the Biostasis Research Institute aimed at creating human organ banks through the cryogenic storage of organs donated for transplantation.
Galectin Therapeutics Inc., the leader in developing carbohydrate-based therapeutic compounds to inhibit galectin receptors, today announced the formation of its Liver Fibrosis Clinical Trials Advisory Board comprised of key opinion leaders from Emory Hospital and School of Medicine, Massachusetts General Hospital and Harvard School of Medicine, University of Michigan Hospital and School of Medicine, Mount Sinai Hospital and School of Medicine, and University of Wisconsin Hospital and School of Medicine.
The George Washington University School of Public Health and Health Services (GW) today released a report representing consensus findings from a cross-section of stakeholders that could help transform the process used to evaluate interventions to treat obesity, a public health crisis that now affects one in three adults. The report, "Obesity Drug Outcome Measures," results from a stakeholder dialogue group convened by GW that, over a period of nine months, explored why development and approval of obesity drugs have proven so difficult.
Patients undergoing percutaneous coronary intervention (PCI), a coronary artery widening procedureused to treat heart disease, are at high risk for obstructive sleep apnea (OSA), according to new research presented at the 2015 American Thoracic Society International Conference.
› Verified 1 days ago
Nataliya Melnyk, M.D Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 500 Upper Chesapeake Dr, Bel Air, MD 21014 Phone: 443-643-3010 Fax: 443-643-3011 | |
Dr. Dhiraj Gurung, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 500 Upper Chesapeake Dr, Bel Air, MD 21014 Phone: 443-643-1000 | |
Qinglin Gao, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 500 Upper Chesapeake Dr, Bel Air, MD 21014 Phone: 443-643-1500 Fax: 443-643-1505 | |
Sudarshan Paudel, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 520 Upper Chesapeake Dr Ste 201, Bel Air, MD 21014 Phone: 443-643-3800 | |
Dr. Kechi Amadi-obi, M.D Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 500 Upper Chesapeake Dr, Bel Air, MD 21014 Phone: 443-643-1500 Fax: 443-643-1505 | |
Frank Sparandero, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1032 Barrymore Dr, Bel Air, MD 21014 Phone: 908-938-1436 | |
Alan Sweatman, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 500 Upper Chesapeake Dr, Bel Air, MD 21014 Phone: 443-643-1000 |